Fees for JHM IRB Review

March 2012

 Effective 3/1/2012, there will be an increase in the JHM IRB review fees for any commercially funded study with financial support in excess of $10,000. This affects studies submitted and/or approved on or after the March 1, 2012 date. For studies approved prior to 3/1/2012, continuing review fees will remain at the previous level of $1000.  As in the past, the JHM IRB only charges for initial and annual continuing reviews, not for changes in research. Federally funded studies and unsponsored studies are not charged review fees. The JHM IRB review fees are listed in the chart below. See the memo from Daniel Ford, M.D., M.P.H. regarding the increase.

As was stated in January 1, 2007, all new applications for human subjects research require submission to the JHM IRBs using the eIRB system. New studies cannot be submitted to WIRB.

The contractual relationship with WIRB remains as they continue to review amendments, change in investigators, continuing reviews, etc. for open studies originally reviewed and approved by them. The commercial/industry sponsor should be billed by WIRB for review fees using the sponsor contact information provided by the PI for all actions reviewed by WIRB unless alternate billing/payment arrangements were approved by the JHM/WIRB Liaison. The School of Medicine will continue to be billed by WIRB for all review actions on federally funded JHU submitted studies initially approved by WIRB.

The JHM IRB review fees will be charged against the study internal order number or to the designated departmental/divisional internal order at the time of IRB approval.

Listed below are the fees that the School of Medicine will charge for commercially funded human subjects research studies. See the WIRB web page http://www.wirb.com for their current fee structure.